US Stock MarketDetailed Quotes

Lyra Therapeutics (LYRA)

Watchlist
  • 0.7399
  • +0.0349+4.95%
15min DelayClose May 1 13:30 ET
1.31MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyra Therapeutics (LYRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-74.05%398K
-96.65%7K
-87.18%25K
-69.40%183K
-65.60%183K
-1.54%1.53M
43.15%209K
-64.15%195K
30.57%598K
29.76%532K
Operating revenue
-74.05%398K
-96.65%7K
-87.18%25K
-69.40%183K
-65.60%183K
-1.54%1.53M
43.15%209K
-64.15%195K
30.57%598K
29.76%532K
Cost of revenue
Gross profit
Operating expense
-51.90%29.95M
-30.65%6.92M
-36.10%6.28M
-53.21%8.61M
-66.17%8.14M
-7.18%62.27M
-39.99%9.98M
-43.39%9.83M
19.74%18.4M
35.73%24.06M
Selling and administrative expenses
-37.62%11.54M
-29.70%2.54M
-43.12%2.24M
-31.87%3.5M
-43.92%3.26M
-2.92%18.5M
-17.08%3.61M
-21.43%3.93M
12.45%5.14M
13.48%5.82M
-General and administrative expense
-37.62%11.54M
-29.70%2.54M
-43.12%2.24M
-31.87%3.5M
-43.92%3.26M
-2.92%18.5M
-17.08%3.61M
-21.43%3.93M
12.45%5.14M
13.48%5.82M
Research and development costs
-57.93%18.41M
-31.19%4.38M
-31.43%4.05M
-61.47%5.11M
-73.26%4.88M
-8.88%43.77M
-48.13%6.36M
-52.28%5.9M
22.83%13.26M
44.79%18.24M
Operating profit
51.34%-29.55M
29.23%-6.91M
35.07%-6.26M
52.66%-8.43M
66.18%-7.96M
7.32%-60.73M
40.73%-9.77M
42.72%-9.64M
-19.41%-17.81M
-35.87%-23.52M
Net non-operating interest income expense
-61.62%1.13M
-61.15%169K
-55.56%256K
-52.05%410K
-72.56%298K
-34.39%2.95M
-67.49%435K
-51.68%576K
-4.68%855K
1.31%1.09M
Non-operating interest income
-61.62%1.13M
-61.15%169K
-55.56%256K
-52.05%410K
-72.56%298K
-34.39%2.95M
-67.49%435K
-51.68%576K
-4.68%855K
1.31%1.09M
Other net income (expense)
98.63%-488K
87.39%-207K
100.75%21K
101.87%583K
-885K
-2,137.12%-35.62M
-1.64M
-2.8M
-1,857.85%-31.17M
Special income (charges)
95.88%-1.47M
87.39%-207K
100.75%21K
98.72%-398K
---885K
-2,137.12%-35.62M
---1.64M
---2.8M
-1,857.85%-31.17M
--0
-Less：Restructuring and merger&acquisition
-86.52%1.47M
-87.39%207K
-100.75%-21K
-93.83%398K
--885K
--10.9M
--1.64M
--2.8M
--6.45M
--0
-Less:Impairment of capital assets
--0
--0
--0
--0
----
1,452.70%24.72M
--0
--0
1,452.70%24.72M
----
Other non- operating income (expenses)
--981K
--0
----
--981K
----
----
----
----
----
----
Income before tax
69.05%-28.91M
36.67%-6.95M
49.60%-5.98M
84.55%-7.44M
61.93%-8.54M
-49.14%-93.4M
27.52%-10.97M
24.11%-11.87M
-208.34%-48.12M
-38.16%-22.44M
Income tax
-71.79%11K
-66.67%2K
-57.14%3K
-83.33%2K
-71.43%4K
-33.90%39K
-64.71%6K
-56.25%7K
0.00%12K
0.00%14K
Net income
69.05%-28.92M
36.69%-6.95M
49.60%-5.98M
84.55%-7.44M
61.93%-8.55M
-49.07%-93.44M
27.56%-10.98M
24.14%-11.87M
-208.18%-48.13M
-38.12%-22.45M
Net income continuous Operations
69.05%-28.92M
36.69%-6.95M
49.60%-5.98M
84.55%-7.44M
61.93%-8.55M
-49.07%-93.44M
27.56%-10.98M
24.14%-11.87M
-208.18%-48.13M
-38.12%-22.45M
Minority interest income
Net income attributable to the parent company
69.05%-28.92M
36.69%-6.95M
49.60%-5.98M
84.55%-7.44M
61.93%-8.55M
-49.07%-93.44M
27.56%-10.98M
24.14%-11.87M
-208.18%-48.13M
-38.12%-22.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.05%-28.92M
36.69%-6.95M
49.60%-5.98M
84.55%-7.44M
61.93%-8.55M
-49.07%-93.44M
27.56%-10.98M
24.14%-11.87M
-208.18%-48.13M
-38.12%-22.45M
Basic earnings per share
74.05%-18.62
54.58%-3.77
62.73%-3.38
85.01%-5.51
62.86%-6.5
-13.89%-71.75
24.55%-8.3
32.81%-9.07
-104.22%-36.76
20.45%-17.5
Diluted earnings per share
74.05%-18.62
54.58%-3.77
62.73%-3.38
85.01%-5.51
62.86%-6.5
-13.89%-71.75
24.55%-8.3
32.81%-9.07
-104.22%-36.76
20.45%-17.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -74.05%398K-96.65%7K-87.18%25K-69.40%183K-65.60%183K-1.54%1.53M43.15%209K-64.15%195K30.57%598K29.76%532K
Operating revenue -74.05%398K-96.65%7K-87.18%25K-69.40%183K-65.60%183K-1.54%1.53M43.15%209K-64.15%195K30.57%598K29.76%532K
Cost of revenue
Gross profit
Operating expense -51.90%29.95M-30.65%6.92M-36.10%6.28M-53.21%8.61M-66.17%8.14M-7.18%62.27M-39.99%9.98M-43.39%9.83M19.74%18.4M35.73%24.06M
Selling and administrative expenses -37.62%11.54M-29.70%2.54M-43.12%2.24M-31.87%3.5M-43.92%3.26M-2.92%18.5M-17.08%3.61M-21.43%3.93M12.45%5.14M13.48%5.82M
-General and administrative expense -37.62%11.54M-29.70%2.54M-43.12%2.24M-31.87%3.5M-43.92%3.26M-2.92%18.5M-17.08%3.61M-21.43%3.93M12.45%5.14M13.48%5.82M
Research and development costs -57.93%18.41M-31.19%4.38M-31.43%4.05M-61.47%5.11M-73.26%4.88M-8.88%43.77M-48.13%6.36M-52.28%5.9M22.83%13.26M44.79%18.24M
Operating profit 51.34%-29.55M29.23%-6.91M35.07%-6.26M52.66%-8.43M66.18%-7.96M7.32%-60.73M40.73%-9.77M42.72%-9.64M-19.41%-17.81M-35.87%-23.52M
Net non-operating interest income expense -61.62%1.13M-61.15%169K-55.56%256K-52.05%410K-72.56%298K-34.39%2.95M-67.49%435K-51.68%576K-4.68%855K1.31%1.09M
Non-operating interest income -61.62%1.13M-61.15%169K-55.56%256K-52.05%410K-72.56%298K-34.39%2.95M-67.49%435K-51.68%576K-4.68%855K1.31%1.09M
Other net income (expense) 98.63%-488K87.39%-207K100.75%21K101.87%583K-885K-2,137.12%-35.62M-1.64M-2.8M-1,857.85%-31.17M
Special income (charges) 95.88%-1.47M87.39%-207K100.75%21K98.72%-398K---885K-2,137.12%-35.62M---1.64M---2.8M-1,857.85%-31.17M--0
-Less：Restructuring and merger&acquisition -86.52%1.47M-87.39%207K-100.75%-21K-93.83%398K--885K--10.9M--1.64M--2.8M--6.45M--0
-Less:Impairment of capital assets --0--0--0--0----1,452.70%24.72M--0--01,452.70%24.72M----
Other non- operating income (expenses) --981K--0------981K------------------------
Income before tax 69.05%-28.91M36.67%-6.95M49.60%-5.98M84.55%-7.44M61.93%-8.54M-49.14%-93.4M27.52%-10.97M24.11%-11.87M-208.34%-48.12M-38.16%-22.44M
Income tax -71.79%11K-66.67%2K-57.14%3K-83.33%2K-71.43%4K-33.90%39K-64.71%6K-56.25%7K0.00%12K0.00%14K
Net income 69.05%-28.92M36.69%-6.95M49.60%-5.98M84.55%-7.44M61.93%-8.55M-49.07%-93.44M27.56%-10.98M24.14%-11.87M-208.18%-48.13M-38.12%-22.45M
Net income continuous Operations 69.05%-28.92M36.69%-6.95M49.60%-5.98M84.55%-7.44M61.93%-8.55M-49.07%-93.44M27.56%-10.98M24.14%-11.87M-208.18%-48.13M-38.12%-22.45M
Minority interest income
Net income attributable to the parent company 69.05%-28.92M36.69%-6.95M49.60%-5.98M84.55%-7.44M61.93%-8.55M-49.07%-93.44M27.56%-10.98M24.14%-11.87M-208.18%-48.13M-38.12%-22.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.05%-28.92M36.69%-6.95M49.60%-5.98M84.55%-7.44M61.93%-8.55M-49.07%-93.44M27.56%-10.98M24.14%-11.87M-208.18%-48.13M-38.12%-22.45M
Basic earnings per share 74.05%-18.6254.58%-3.7762.73%-3.3885.01%-5.5162.86%-6.5-13.89%-71.7524.55%-8.332.81%-9.07-104.22%-36.7620.45%-17.5
Diluted earnings per share 74.05%-18.6254.58%-3.7762.73%-3.3885.01%-5.5162.86%-6.5-13.89%-71.7524.55%-8.332.81%-9.07-104.22%-36.7620.45%-17.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -